Bio-Path Holdings Inc.

5.55+0.0300+0.54%Vol 112.02K1Y Perf 3.64%
Apr 20th, 2021 16:00 DELAYED
BID5.44 ASK5.57
Open5.45 Previous Close5.52
Pre-Market- After-Market5.55
 - -  - -%
Target Price
12.50 
Analyst Rating
Strong Buy 1.00
Potential %
125.23 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12 mo.
-/-/- 
Value Ranking
 —    -
Insiders Value % 3/6/12 mo.
-/-/- 
Growth Ranking
 —    -
Insiders Shares Cnt. % 3/6/12 mo.
-/-/- 
Income Ranking
 —    -
Market Cap38.56M 
Earnings Rating
Strong Buy
Price Range Ratio 52W %
11.45 
Earnings Date
21st May 2021

Today's Price Range

5.375.60

52W Range

3.1224.34

5 Year PE Ratio Range

-13.60-2.60

Summary:

Sell

Technical Indicators: Sell
Moving Averages: Strong Sell
Performance
1 Week
-10.05%
1 Month
-22.70%
3 Months
28.18%
6 Months
35.70%
1 Year
3.64%
3 Years
-85.16%
5 Years
-99.02%
10 Years
-92.70%

TickerPriceChg.Chg.%
BPTH5.550.03000.54
AAPL133.11-1.7300-1.28
GOOG2 293.63-8.7700-0.38
MSFT258.26-0.4800-0.19
XOM55.29-1.1900-2.11
WFC42.54-1.3400-3.05
JNJ166.483.79002.33
FB302.650.41000.14
GE13.06-0.4000-2.97
JPM149.27-3.3800-2.21
Earnings HistoryEstimateReportedSurprise %
Q04 2020-0.78-0.5726.92
Q03 2020-0.83-0.803.61
Q02 2020-0.89-0.5538.20
Q01 2020-0.67-0.90-34.33
Q04 2019-0.69-0.72-4.35
Q03 2019-0.74-0.78-5.41
Q02 2019-0.60-0.87-45.00
Q01 2019--0.89-
Earnings Per EndEstimateRevision %Trend
3/2021 QR-0.5033.33Positive
6/2021 QR-0.4522.41Positive
12/2021 FY-1.999.55Positive
12/2022 FY-1.97--
Next Report Date21st May 2021
Estimated EPS Next Report-0.50
Estimates Count2
EPS Growth Next 5 Years %-
Volume Overview
Volume112.02K
Shares Outstanding6.95M
Trades Count724
Dollar Volume3.04M
Avg. Volume2.11M
Avg. Weekly Volume215.15K
Avg. Monthly Volume1.37M
Avg. Quarterly Volume2.47M

Bio-Path Holdings Inc. (NASDAQ: BPTH) stock closed at 5.55 per share at the end of the most recent trading day (a 0.54% change compared to the prior day closing price) with a volume of 116.71K shares and market capitalization of 38.56M. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Biotechnology industry, Healthcare sector and employs 9 people. Bio-Path Holdings Inc. CEO is Peter H. Nielsen.

The one-year performance of Bio-Path Holdings Inc. stock is 3.64%, while year-to-date (YTD) performance is 58.57%. BPTH stock has a five-year performance of -99.02%. Its 52-week range is between 3.12 and 24.34, which gives BPTH stock a 52-week price range ratio of 11.45%

Bio-Path Holdings Inc. currently has a PE ratio of -2.00, a price-to-book (PB) ratio of 2.57, a price-to-sale (PS) ratio of -, a price to cashflow ratio of -, a PEG ratio of 2.32, a ROA of -52.89%, a ROC of -71.82% and a ROE of -57.23%. The company’s profit margin is -%, its EBITDA margin is -%, and its revenue ttm is $0.00 , which makes it $0.00 revenue per share.

Of the last four earnings reports from Bio-Path Holdings Inc., there were 3 positive earnings surprise and 1 negative earnings surprise. The company has EPS estimate of $-0.50 for the next earnings report. Bio-Path Holdings Inc.’s next earnings report date is 21st May 2021.

The consensus rating of Wall Street analysts for Bio-Path Holdings Inc. is Strong Buy (1), with a target price of $12.5, which is +125.23% compared to the current price. The earnings rating for Bio-Path Holdings Inc. stock is Strong Buy (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Bio-Path Holdings Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Bio-Path Holdings Inc. has a Sell technical analysis rating based on Technical Indicators (ADX : 38.69, ATR14 : 0.82, CCI20 : -198.51, Chaikin Money Flow : -0.59, MACD : -0.04, Money Flow Index : 88.72, ROC : -21.37, RSI : 43.05, STOCH (14,3) : 4.91, STOCH RSI : 0.00, UO : 33.17, Williams %R : -95.09), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Bio-Path Holdings Inc. in the last 12-months were:

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
1 (100.00 %)
1 (100.00 %)
1 (100.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Summary RatingStrong Buy
1.00
Strong Buy
1.00
Strong Buy
1.00

Bio-Path Holdings Inc.

Bio-Path Holdings Inc is a clinical and preclinical stage oncology-focused RNAi nanoparticle drug development company. It is engaged in utilizing a novel technology that achieves systemic delivery for target specific protein inhibition for any gene product that is over-expressed in disease. The company's lead drug candidate, prexigebersen, is in the efficacy portion of Phase 2 clinical trial for acute myeloid leukemia (AML) in combination with low-dose cytarabine (LDAC) and combination with decitabine. Its other drugs are BP1002 and BP1003.

CEO: Peter H. Nielsen

Telephone: +1 832 742-1357

Address: 4710 Bellaire Boulevard, Bellaire 77401, TX, US

Number of employees: 9

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

63%38%

Bearish Bullish

52%48%

Bearish Bullish

53%47%

News

Stocktwits